Damora Therapeutics, Inc. (NASDAQ:DMRA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chau Quang Khuong Other companies: Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Whitehawk Therapeutics, Inc. (Director · Jun 18, 2019 – Jun 18, 2019 · Past); Synlogic Inc (Director · Jun 5, 2019 – Apr 20, 2021 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 22, 2023 · Past); Inspire Medical Systems, Inc. (Director · Apr 10, 2019 – Oct 9, 2020 · Past) | Director · Oct 28, 2020 – Jun 14, 2023 · Past |
| Cameron Turtle Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Spyre Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 22, 2023); BridgeBio Pharma, Inc. (See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past); Eidos Therapeutics Inc (Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past) | Board Director · Since at least Mar 23, 2026 |
| Anne Prener Other companies: Keros Therapeutics, Inc. (Director · Since at least Jun 25, 2026); Kaleido Biosciences, Inc. (Director · Jun 30, 2021 – Jun 30, 2021 · Past); Rubius Therapeutics Inc (Director · May 12, 2021 – May 12, 2022 · Past) | Director · Since at least Jan 8, 2021 |
| Chris Cain Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Viridian Therapeutics, Inc. (Director · Since at least Mar 10, 2025); Cogent Biosciences, Inc. (Director · Since at least Jul 6, 2020) | Board Director · Since at least Nov 10, 2025 |
| Peter Harwin Other companies: Oruka Therapeutics, Inc. (Director · Since at least Nov 5, 2026); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Nov 4, 2026) | Chairman of the Board · Since at least May 12, 2026 |
| Amy B. Wechsler Other companies: Bausch Health Companies Inc. (Director · Since at least Sep 30, 2020) | Director · Since at least Oct 11, 2024 |
| Becker Hewes Other companies: Blueprint Medicines Corp (Chief Medical Officer · Since at least Jan 11, 2021) | Chief Medical Officer · Since at least Jan 5, 2026 |
| David Shapiro Other companies: Design Therapeutics, Inc. (Director · Since at least Mar 31, 2026) | Director · Since at least Oct 28, 2020 |
| Jonathan Freve Other companies: Spring Bank Pharmaceuticals Inc (CFO & Treasurer · May 5, 2016 – Mar 5, 2020 · Past) | Chief Financial Officer · Oct 28, 2020 – Jan 3, 2024 · Past |
| Andrew Cheng | Board Director · Since at least Aug 10, 2026 |
| Bertil Lindmark | Chief Medical Officer · Oct 28, 2020 – Jan 4, 2023 · Past |
| Brian Burkavage | Senior Vice President, Finance · Since at least May 12, 2026 |
| Garrett Winslow | General Counsel · Since at least May 12, 2026 |
| Hans T Schambye | Chief Executive Officer, Director · Since at least Oct 28, 2020 |
| Jennifer Jarrett | President and Chief Executive Officer in March 2026, Board Director · Since at least Mar 30, 2026 |
| Jim Baker | Chief Corporate Affairs Officer · Since at least Oct 5, 2026 |
| Julianne Bruno | Director · Since at least Nov 10, 2025 |
| Matthew Kronmiller | EVP Strategy and CBO · Oct 7, 2024 – Jan 3, 2025 · Past |
| Michael Landsittel | Board Director · Since at least Nov 5, 2026 |
| Sherwin Sattarzadeh | Chief Operating Officer · Since at least Jan 5, 2026 |
| Soren Moller | Director · Oct 28, 2020 – Oct 28, 2020 · Past |
| Stephanie Oestreich | Chief Business Officer · Jan 5, 2022 – Jan 4, 2023 · Past |